Get the Stockscreener App
87.22
1.18%
-1.04
After Hours:
87.22
Globus Medical Inc stock is traded at $87.22, with a volume of 762.48K.
It is down -1.18% in the last 24 hours and down -4.91% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$88.26
Open:
$87.67
24h Volume:
762.48K
Relative Volume:
0.45
Market Cap:
$11.67B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
65.09
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
-0.32%
1M Performance:
-4.91%
6M Performance:
+40.97%
1Y Performance:
+3.82%
1-Day Range:
$86.06
$88.92
1-Week Range:
$86.06
$89.64
52-Week Range:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
87.22 | 11.81B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Upgrade | Needham | Hold → Buy |
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Nov-07-25 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-25 | Upgrade | Truist | Hold → Buy |
| Oct-28-25 | Resumed | Stifel | Hold |
| May-27-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - marketscreener.com
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
Madison Asset Management LLC Sells 58,971 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Candriam S.C.A. Sells 43,909 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (NYSE:GMED): A Prime Example of Affordable Growth - ChartMill
Thrivent Financial for Lutherans Sells 194,537 Shares of Globus Medical, Inc. $GMED - MarketBeat
Foresight Group Ltd Liability Partnership Raises Stake in Globus Medical, Inc. $GMED - MarketBeat
New York State Common Retirement Fund Sells 77,412 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Globus Medical (GMED) Valuation Check After Mixed Short Term Share Performance - Yahoo Finance
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance
Is Globus Medical (GMED) Pricing Fair After The Recent Healthcare Sector Reassessment? - Sahm
Van Berkom & Associates Inc. Purchases 48,906 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical IncA (NYSE:GMED) Shows Strong Fundamentals and Technical Setup for Growth - ChartMill
Globus Medical, Inc. (GMED): Analyst Consensus and Growth Potential Highlight an 18% Upside - DirectorsTalk Interviews
Zacks Research Lifts Earnings Estimates for Globus Medical - MarketBeat
At US$90.68, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - 富途牛牛
Dip Buying: Will Globus Medical Inc benefit from government policy2025 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CEO Change: Can Origin Materials Inc outperform under higher oil prices2025 AllTime Highs & Growth Focused Entry Point Reports - baoquankhu1.vn
Assessing Globus Medical (GMED) Valuation After Investor Letter Highlights Reaccelerating Spine Growth And Integration Progress - Sahm
Needham upgrades Globus Medical stock to Buy on margin expansion By Investing.com - Investing.com Canada
Needham Upgrades Globus Medical to Buy From Hold, Sets $112 Price Target - marketscreener.com
The Analyst Verdict: Globus Medical In The Eyes Of 13 Experts - Benzinga
This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Analyst Upgrade: Needham Upgrades GMED to 'Buy' Rating | GMED St - GuruFocus
Globus Medical (NYSE:GMED) Upgraded by Needham & Company LLC to "Buy" Rating - MarketBeat
Needham Upgrades Globus Medical (GMED) - Nasdaq
TD Cowen Upgrades Globus Medical (NYSE:GMED) to "Strong-Buy" - MarketBeat
Cambiar Investors LLC Sells 55,919 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Momentum Stock - sharewise.com
Y Intercept Hong Kong Ltd Cuts Position in Globus Medical, Inc. $GMED - MarketBeat
Here’s What Lifted Globus Medical (GMED) in Q4 - Insider Monkey
TD Cowen Initiates Coverage on Globus Medical With Buy Rating, $110 Price Target - marketscreener.com
Globus Medical, Inc. $GMED Shares Sold by Strs Ohio - MarketBeat
Globus Medical stock operating in a buy zone after strong preliminary results - MSN
Is Globus Medical (GMED) Attractively Priced After Recent P/E And DCF Valuation Signals - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Analysis: Exploring A Robust 15% Potential Upside - DirectorsTalk Interviews
TD Cowen assumes coverage on Globus Medical stock with Buy rating - Investing.com Canada
What Catalysts Are Quietly Shifting The Story For Globus Medical (GMED)? - Yahoo Finance
Here's Why Globus Medical (GMED) is a Strong Growth Stock - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Holdings in Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical (GMED) beat estimates again in its next earnings report? - MSN
Lightrock Netherlands B.V. Increases Stock Position in Globus Medical, Inc. $GMED - MarketBeat
Is Globus Medical (GMED) Pricing Reflect Its DCF Upside And Mixed P/E Signals? - Sahm
Aug Update: What is Globus Medical Incs TAM Total Addressable Market2025 Market Sentiment & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Spine Biologics Market Dynamics and Contributions - openPR.com
Massachusetts Financial Services Co. MA Sells 165,185 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Globus Medical (GMED) Valuation Check After Updated Guidance And NuVasive Synergy Outlook - Sahm
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):